tm
Seeing Is Believing
tm
Seeing Is Believing
CRDF is currently covered by 2 analysts with an average price target of $11.67. This is a potential upside of $9.37 (407.39%) from yesterday's end of day stock price of $2.3.
Cardiff Oncology's activity chart (see below) currently has 13 price targets and 25 ratings on display. The stock rating distribution of CRDF is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 270 days.
Highest price target for CRDF is $13, Lowest price target is $10, average price target is $11.5.
Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 13-Dec-2024. First documented stock forecast 08-Oct-2020.
Currently out of the existing stock ratings of CRDF, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$7.56 (309.84%)
$7
8 months 6 days ago
(13-Dec-2024)
1/6 (16.67%)
$6.08 (155.10%)
547
Buy
$13
$10.56 (432.79%)
$14
9 months 11 days ago
(08-Nov-2024)
0/5 (0%)
$9.92 (322.08%)
Buy
$5
$2.56 (104.92%)
$6
2 years 10 months 23 days ago
(27-Sep-2022)
1/3 (33.33%)
$3.45 (222.58%)
533
Buy
$25
$23.61 (1698.56%)
3 years 11 months 11 days ago
(09-Sep-2021)
0/1 (0%)
$18.01 (257.65%)
What is CRDF (Cardiff Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on CRDF (Cardiff Oncology) with a proven track record?
Which analyst has the current lower performing score on CRDF (Cardiff Oncology) with a proven track record?
Which analyst has the most public recommendations on CRDF (Cardiff Oncology)?
Which analyst is the currently most bullish on CRDF (Cardiff Oncology)?
Which analyst is the currently most reserved on CRDF (Cardiff Oncology)?
